Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

NCT01240161 is registered in ClinicalTrials.gov with Marcelo F. Di Carli, MD, FACC as lead sponsor.

NCT NCT01240161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Translational Platform for Biomarker Discovery in Brain Tumors
Lead sponsor
Marcelo F. Di Carli, MD, FACC
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
March 31, 2016
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

high grade glioma